Intermittent Versus Continuous Enteral Nutrition in Mechanically Ventilated Patients in the Medical Intensive Care Unit
1 other identifier
interventional
20
1 country
1
Brief Summary
Evaluate effective delivery of goal nutrition with intermittent as compared with continuous enteral nutrition schedules, as defined by percentage of recommended calories that patient receives per day of interest.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2020
CompletedFirst Posted
Study publicly available on registry
June 18, 2020
CompletedStudy Start
First participant enrolled
July 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 7, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 7, 2022
CompletedMarch 3, 2025
February 1, 2025
2.4 years
May 19, 2020
February 28, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Recommended calories
percentage of recommended calories that patient receives per day of interest during study period
Intubation day 1 to intubation day 10
Secondary Outcomes (8)
Percentage of patients with aspiration
Intubation day 1 to intubation day 10
Percentage of patients experiencing intolerance of feeding
Intubation day 1 to intubation day 10
feasibility: proportion complete protocol
Intubation day 1 to intubation day 10
delirium
intubation day 1 until 14 days later
urine 6-sulfatoxymelatonin acrophase
day 1 to 3 following initiation of feeds
- +3 more secondary outcomes
Study Arms (2)
Intermittent feed
EXPERIMENTALPatients will be assigned to receive intermittent enteral feeding protocol. They will receive four equal volume feeds at 8:00, 12:00, 16:00, and 20:00 hours.
Continuous feeds
EXPERIMENTALPatients will be assigned to receive continuous enteral feeding protocol. Typical goal rates are in the range of 60 to 80 mL per hour for 24 hours per day.
Interventions
Patients will be assigned to receive intermittent enteral feeding protocol. They will receive four equal volume feeds at 8:00, 12:00, 16:00, and 20:00 hours.
Patients will be assigned to receive continuous enteral feeding protocol. Typical goal rates are in the range of 60 to 80 mL per hour for 24 hours per day.
Eligibility Criteria
You may qualify if:
- MICU Yale New Haven Hospital
- Age \>= 18 years old.
- Patients mechanically ventilated via endotracheal tube
- Patients intubated within 72 hours of hospital admission
- First intubation of current hospitalization
- First MICU admission of current hospitalization
You may not qualify if:
- Patient has opted out of research participation via institutional patient portal.
- At significant risk for gastrointestinal intolerance of intermittent bolus feeds:
- Structural gastrointestinal obstruction (such as tumor).
- Chronic enteral nutrition (prior to current admission).
- History of significant esophageal dysmotility (history of GERD is acceptable) or clinically significant GE junction incompetence
- Unable to have head of bed elevated at least 30 degrees while intubated and being fed (this is standard protocol).
- History of small bowel obstruction or ileus on current admission or within last 1 month.
- History of gastroparesis.
- Percutaneous gastrostomy tube or tracheostomy.
- History of ongoing aspiration as determined by a speech medicine specialist or other medical professional or a patent who required adjustment of diet (e.g., thickening of liquids) prior to hospitalization.
- History of significant esophageal dysmotility (history of GERD is acceptable) or clinically significant GE junction incompetence
- At risk of refeeding syndrome.
- Pregnant patients.
- Patients receiving neuromuscular blockade.
- Patients with glycemic emergency (HHNK, DKA, severe hypoglycemia resulting in MICU admission) or patients controlling their sugar / insulin dosing via continuous glucose monitoring
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
Study Sites (1)
Yale New Haven Hospital, York Street Campus
New Haven, Connecticut, 06520, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Melissa P Knauert, MD, PhD
Yale University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The care team and study staff in the ICU will be aware of arm assignment. Study staff abstracting outcome data will be blinded to arm assignement.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 19, 2020
First Posted
June 18, 2020
Study Start
July 7, 2020
Primary Completion
December 7, 2022
Study Completion
December 7, 2022
Last Updated
March 3, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share
De-identified individual participant data can be made available upon request.